Skip to main content
. 2013 Jan 17;4(6):379–387. doi: 10.4161/bioe.23574

Table 2. Health benefits of probiotic bacteria and their proposed mechanisms.

Health benefits Proposed mechanism
Resistance to enteric pathogens Antagonism
Increased antibody production
Colonization resistance
Limiting access of enteric pathogens (pH, bacteriocins, antimicrobial peptides, lactic acid production)
Aid in lactose metabolism Bacterial lactase hydrolyzes lactose in the small intestine
Small bowel bacterial overgrowth Decrease toxic metabolite production
Normalize small bowel flora
Antibacterial characteristics
Immune system modulation Strengthening of non-specific and antigen-specific defense
Regulate/influence Th1/Th2 cell activation
Production of anti-inflammatory cytokines
Anticolon cancer effect Antimutagenic and anticarcinogenic activity
Detoxification of carcinogenic metabolites
Stimulation of immune function
Decreased detoxification/excretion of toxic microbial metabolites Increased bifidobacterial cell counts and shift from a preferable protein-to carbohydrate-metabolizing microbial community
Anti-Allergic activity (eczema or atopic dermatitis, asthma) Prevention of antigen translocation into blood stream
Prevent excessive immunologic responses to increased amount of antigen
Blood lipids, heart disease Assimilation of cholestrol by bacterial cell
Alteration in the activity of bile salt hydrolase (BSH)
Urogenital infections Adhesion to urinary and vaginal tract cells
Competitive exclusion
Necrotizing enterocolitis Decrease in TLRs and signaling molecules and increase in negative regulations
Reduction in IL-8 response
Rotavirus gastroenteritis Increased IgA response to the virus
Inflammatory bowel disease Enhancement of mucosal barrier function
Crohn disease Reduction in proinflammatory cytokines production

Adapted from Nagpal et al.23

HHS Vulnerability Disclosure